Home | Business News | Browse by Publication | M | M2 Presswire

Biotech Holdings vs. the Global Market.

Article Excerpt
M2 PRESSWIRE-31 August 2006-www.streetinvesting.com: Biotech Holdings vs. the Global Market(C)1994-2006 M2 COMMUNICATIONS LTD

RDATE:31082006

Streetinvesting.com is the author of this release. This release is a result of our current concentration on Biotech Holdings (0TCBB:BIOHF)(TSX-V:BIO.V) and their latest corporate developments and market performance. Our goal is to help investors seek a diversified portfolio by introducing techniques to help grasp a better understanding and concept of the market and the daily activities that a public company experiences. The first stage of this process is to continually track Biotech Holdings and use the information that we may find to our advantage. To learn more and become part of the acclaimed online financial newsletter community, visit www.streetinvesting.com for a complimentary subscription.

Biotech Holdings, a company which has developed and has begun manufacturing, marketing and distributing, "Sucanon," a new drug for treatment of symptoms of Type II Diabetes, was up 32.67% Wednesday, with approximately 727,272 shares having traded hands come the toll of the day's closing bell.

Wall Street continued its advance Wednesday and although the gains were not as pronounced as those...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!